Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Morten Ejby Hansen *Department of Biotechnology and Bioengineering, Technical University of Denmark, Lyngby, Denmark.
Mikiyasu Sakanaka *Faculty of Bioresources and Environmental Sciences, Ishikawa Prefectural University, Nonoichi, Ishikawa Prefecture, Japan.ORCID 0000-0002-4223-0926
Mathias Jensen *Department of Biotechnology and Bioengineering, Technical University of Denmark, Lyngby, Denmark.ORCID 0000-0002-8760-6616
Hiroka SakanakaDepartment of Biotechnology and Bioengineering, Technical University of Denmark, Lyngby, Denmark.
Michael Jakob PichlerDepartment of Biotechnology and Bioengineering, Technical University of Denmark, Lyngby, Denmark.
Shingo MaedaFaculty of Bioresources and Environmental Sciences, Ishikawa Prefectural University, Nonoichi, Ishikawa Prefecture, Japan.
Julie Franck HøvringDepartment of Chemistry, Technical University of Denmark, Lyngby, Denmark.ORCID 0000-0003-4762-5529
Aruto NakajimaGraduate School of Biostudies, Kyoto University, Kyoto, Japan.
Sonja KunstmannDepartment of Biotechnology and Bioengineering, Technical University of Denmark, Lyngby, Denmark.
Tine Sofie NielsenDepartment of Biotechnology and Bioengineering, Technical University of Denmark, Lyngby, Denmark.
Günther Herbert Johannes PetersDepartment of Chemistry, Technical University of Denmark, Lyngby, Denmark.ORCID 0000-0001-9754-2663
Dirk Jan SlotboomMembrane Enzymology, Institute for Biomolecular Sciences & Biotechnology, Rijksuniversiteit Groningen, Groningen, the Netherlands.
Jens Preben MorthDepartment of Biotechnology and Bioengineering, Technical University of Denmark, Lyngby, Denmark.
Takane KatayamaGraduate School of Biostudies, Kyoto University, Kyoto, Japan.ORCID 0000-0003-4009-7874
Maher Abou HachemDepartment of Biotechnology and Bioengineering, Technical University of Denmark, Lyngby, Denmark.ORCID 0000-0001-8250-1842
Funding
Japan Society for the Promotion of Science 18K14379, 21H02116Natur og Univers, Det Frie Forskningsråd 4002-00297B, 1026-00386BNovo Nordisk Fonden NNF22OC0077684
6 · The paper itself
Abstract
Human milk oligosaccharides (HMOs) are uniquely rich in the type 1 building block disaccharide lacto- IMPORTANCE: The assembly of the gut microbiota in early life is critical to the health trajectory of human hosts. Breast feeding selects for a
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Uptake of fucosylated type I human milk oligosaccharide blocks by · full record | OpenQuestion